Can ( Genesis 1:29 ) Diet Come To The Rescue of Breast Cancer Patients

Barrons Medical Journal Reporting From Houston Methodist Hospital Houston Texas.

---

Can ( Genesis 1:29 ) Diet Come To The Rescue of Breast Cancer Patients

---

Houston ( AP ) Genomics is now a House Hold name. Genomics is the study of your genes to determine if you have a disease. If you are a

Women forty years old and took a genomic test and found that you where going to get breast cancer what are some of the things that you can do ?

Barrons Medical Journal Interviewed one of Houston Leading Authorities in the Geneis 129 Diet Jan Jordan a Nutritionist, Jan has taught diet & lifestyle from a biblical prospective for over 12 years & is a Naturopathic Doctor, Certified Nutritionist, Certified Christian Counselor, Raw Food Chef and Halleluhjah Acres Health Minister. She can be contacted at janjordannd@yahoo.com

to ask how can genomics and the genesis 129 Diet can help Breast Cancer Patients. Jan says we must start with the quote:

And God said, Behold, I have given you every herb bearing seed, which is upon the face of all the earth, and every tree, in the which is the fruit of a tree yielding seed; to you it shall be for meat.

Jan goes on to explain around the year 1999 she went to her primary care Physician and took a Mammogram and was advised to see a Oncologist. Jan decided to take matters in here hands and treat the lump on her breast without consulting a Oncologist. Jan a nutritionist by education started on the Genesis 129 Diet which is just food with seeds and six months later she says that she was cancer free. It is now 14 years later and still cancer free says that this diet works for her and many other folks. The area of concern is that people that start the diet with stage1 or stage 2-breast cancer and go back to eating their normal diet and this is when the breast cancer reoccurs.

Barrons Medical Journal decided to look in to the science behind the Genesis 129 diet. The association between dietary fat and breast cancer has been examined for a long time, it remains one of the most controversial in nutritional epidemiology (In the early 1940s, animal studies suggested that high-fat diets could stimulate mammary carcinogenesis. This notion was subsequently reinforced by results of international correlation studies and migrant studies; the latter showed that migrant populations that replaced their indigenous low-fat diets with high-fat, Western diets experienced breast cancer incidence rates similar to those of the host populations. Beginning in the mid-1970s, case–control study reports tended to show positive associations between dietary fat intake and breast cancer.

However, the possibility of differential recall of diet between case and control subjects cast doubt on these results Although pooled analyses of subsequent cohort studies failed to show an association between fat intake and the risk of breast cancer a more recent meta-analysis of 14 cohort studies that adjusted for energy intake found that women who consumed the highest levels of total fat had a statistically significant 13% higher risk of breast cancer than those who consumed the lowest levels. Recently reported findings from the Women's Health Initiative (WHI) Randomized Controlled Dietary Modification Trial provided suggestive evidence that a low-fat diet can reduce the incidence of breast cancer incidence, although follow-up was shorter and the reduction in fat intake in the intervention group, smaller than originally planned. The Geneis diet provided the women with

650 calories (kcal) in the form of two pints of semi-skimmed milk, four portions of vegetables (80g/portion), one portion of fruit, a salty low calorie drink and a multivitamin and mineral supplement. God instructs man to eat (Genesis 1:29). The dense living nutrients found in raw foods and their juices produce abundant energy and vibrant health while satisfying our cells’ nutritional needs, controlling hunger efficiently.

Brought To You By Antiques of River Oaks Houston,Tx

•Beverages: Freshly extracted vegetable juices, BarleyMax, CarrotJuiceMax, BeetMax, and remineralized distilled water

•Dairy Alternatives: Fresh almond milk, creamy banana milk, as well as frozen banana, strawberry, or blueberry “fruit creams”

•Fruit: All fresh, as well as unsulphured organic dried fruit (limit fruit to no more than 15% of daily food intake)

•Grains: Soaked oats, raw muesli, dehydrated granola, dehydrated crackers

•Beans: Green beans, peas, sprouted garbanzos, sprouted lentils, and sprouted mung beans

•Nuts & Seeds: Raw almonds, sunflower seeds, macadamia nuts, walnuts, raw almond butter or tahini (consume sparingly)

•Oils and Fats: Extra virgin olive oil, Udo’s Oil, flaxseed oil (the oil of choice for people with cancer, except men with prostate cancer, who may be better served meeting the essential fat needs through freshly ground flaxseed), and avocados

•Seasonings: Fresh or dehydrated herbs, garlic, sweet onions, parsley, and salt-free seasonings

•Sweets: Fruit smoothies, raw fruit pies with nut/date crusts, date-nut squares, etc.

•Vegetables: All raw vegetables

•Soups: Raw soups

Barrons Medical Journal want to make sure that Breast Cancer patient consults with their Doctors.

Breast Cancer Weapons Genomics And Neoadjuvant Chemotherapy Is The 2012 Breast Cancer latest Advancement:

Public & Media --- San Antonio Breast Cancer Symposium: Press Releases

---

Barron's Medical Journal Robert Graham Ph.D. Reporting from San Antonio Breast Cancer Symposium

San Antonio Texas December 8, 2012

---

Breast Cancer Weapons Genomics And Neoadjuvant Chemotherapy Is The 2012 Breast Cancer latest Advancement:

---

San Antonio ( AP ) Genomics is a now a house hold name. Evidence have surfaced again at the San Antonio Breast Cancer Symposium. Barron's Medical Journal reports that hope for young women, those under 35, who get breast cancer out of the blue – especially because they are far more likely than older women to have a hard-to-treat type

of breast cancer called triple negative breast cancer. A chemotherapy treatment called neoadjuvant chemotherapy can actual reduce the size of large triple negative breast cancer tumors. The efficacy of neoadjuvant chemotherapy, as measured by the rate of pathological complete response (the absence of invasive and intraductal disease in the breast and the axillary lymph nodes), varies according to breast-cancer subtype. When anthracyclines, taxanes, and agents directed against anti–human. First degree relatives of Breast Cancer Patients that take a Genomic test and find

that the genes P53, P63, Her-2 and more are the largest candidates neoadjuvant chemotherapy treatments. A Houston base company called Gennxeix researcher work product. lets discuss some of their finding. Gennxeix discovered that some patients with HER2-positive breast cancer tended not respond to HER2-targeted therapies. Also, some patients with triple-negative breast cancers responded to therapies while others didn't. "We have been lumping things together that shouldn't be lumped together The new classifications - four types called HER2 "enriched," luminal A, luminal B and basal-like - categorize breast cancers by their genomic structure using a dizzying array of data points not previously available that have identified new pathways for the cancer to do its damage, making it possible for researchers to identify new places to target disease. Brought To You By Antiques of River Oaks Houston,Tx In what could be seen as the most promising development of this breast cancer study, researchers determined that some basal-like cancers had more in common with an aggressive form of ovarian cancer known as "serous" than with other types of breast cancer. Two other types of breast cancer, accounting for most cases of the disease, arise from the luminal cells that line milk ducts. These cancers have proteins on their surfaces that grab estrogen, fueling their growth. Just about everyone with estrogen-fueled cancer gets the same treatment. Some do well. Others do not. The genetic analysis divided luminal cancers into two distinct subtypes. The luminal A subtype had good prognoses while luminal B did not, suggesting that perhaps patients with luminal A tumors might do well with just hormonal therapy to block estrogen from spurring their cancers while luminal B patients might do better with chemotherapy in addition to hormonal therapy. In some cases, genetic aberrations were so strongly associated with one or the other luminal subtype that they appeared to be the actual cause of the cancer. The better News is that Genomics is on the Clock. Genomics provide a faster cheaper more effective way to detect the Her2 gene by using Semiconductor Sequencing. A example of this technique is Hybrid Pharma Gennxeix Semiconductor Sequencing. "Quantum Theory" In Action for Breast Cancer Patients. A polymerase is an enzyme whose central function is associated with polymers of nucleic acids such as RNA and DNA. The primary function of a polymerase is the polymerization of new DNA or RNA against an existing DNA or RNA template in the processes of replication and transcription. In association with a Hybrid Pharma Gennxeix also uses a Visualize Real-Time Breast Cancer Data using Signal Stochastic Resonance Units Neurons Detection and Analysis for Breast Cancer model after McCulloch-Pitts.Hybrid Pharma computer-assisted diagnosing

of breast cancer from mammograms. Hybrid Pharma works is a genetic network simulation trained with tumor incidence data from knockout experiments. Gennxeix Biotech uses Semiconductor Sequencing Chips that create a direct connection between Biochemical and digital information, bringing these two languages together. Hybrid's chips are designed like any other semiconductor chips. Pairing proprietary semiconductor technology with sequencing chemistry a nucleotide is incorporated into a strand of DNA by a polymerase, a hydrogen ion is released. Gennxeix Biotech used a high-density array of micro-machined wells for bioctechnology process in a massive way. Each well holds a different DNA template. Beneath the wells is an ion-sensitive layer and beneath that a proprietary Ion sensor. HER2 in many patients respond differently. Genomics can be the GPS to Extend life in Breast Cancer Patients. formalin fixed, paraffin embedded techniques and Her-2 Approximately Where do you really come from? And how can this information Solve Breast Cancer? Approximately 30% of malignant breast cancers demonstrate overamplification of the human epidermal receptor type 2 (HER2) gene. HER-2 can be resistant to low-doses of anthracycline-based Hybrid Pharma have demonstrated that they can be used to map DNase (deoxyribonuclease) DNA origins of replication. Hybrid Pharma Recent progress in microarray technology has been related to the development of high resolution microarrays which can map genomic alterations and constitutional variants in DNA copy number at an extremely high resolution for Breast Cancer chemotherapy. formalin fixed, paraffin embedded techniques and Her-2The Good News is that science has advanced. Sections of microarray provide targets for parallel in situ detection of DNA, RNA and protein targets in each specimen on the array. The better News is that Genomics is on the Clock. Genomics provide a faster cheaper more effective way to detect the Her2 gene by using Semiconductor Sequencing. A example of this technique is Hybrid Pharma Semiconductor Sequencing. "Quantum Theory" In Action for Breast Cancer Patients. A polymerase is an enzyme whose central function is associated with polymers of nucleic acids such as RNA and DNA. The primary function of a polymerase is the polymerization of new DNA or RNA against an existing DNA RNA template in the processes of replication and transcription. In association with a Hybrid Pharma also uses a Visualize Real-Time Breast Cancer Data using Signal Stochastic Resonance Units Neurons Detection and Analysis for Breast Cancer model after McCulloch-Pitts. Hybrid Pharma computer-assisted diagnosing of breast cancer from mammograms. Hybrid Pharma Gennxeix works is a genetic network simulation trained with tumor incidence data from knockout experiments. Gennxeix Biotech uses Semiconductor Sequencing Chips that create a direct connection between Biochemical and digital information, bringing these two languages together. Hybrid's chips are designed like any other semiconductor chips. Pairing proprietary semiconductor technology with sequencing chemistry a nucleotide is incorporated into a strand of DNA by a polymerase, a hydrogen ion is released. Gennxeix Biotech used a high-density array of micro-machined wells for bioctechnology process in a massive way. Each well holds a different DNA template. Beneath the wells is an ion-sensitive layer and beneath that a proprietary Ion sensor. HER2 in many patients response differently. Genomics is the GPS to Extend life in Breast Cancer Patients Neoadjuvant chemotherapy (NAC) induces a pathological complete response (pCR) in ~30% of patients with breast cancer. However, many patients have residual cancer after chemotherapy, which correlates with a higher risk of metastatic recurrence and poorer outcome than those who achieve a pCR. We hypothesized that molecular profiling of tumors after NAC would identify genes associated with drug resistance. Digital transcript counting was used to profile surgically resected breast cancers after NAC. Low concentrations of dual specificity

protein phosphatase 4 (DUSP4), an ERK phosphatase, correlated with high post-NAC tumor cell proliferation and with basal-like breast cancer (BLBC) status. BLBC had higher DUSP4 promoter methylation and gene expression patterns of Ras-ERK pathway activation relative to other breast cancer subtypes. DUSP4 overexpression increased chemotherapy-induced apoptosis, whereas DUSP4 depletion dampened the response to chemotherapy. Reduced DUSP4 expression in primary tumors after NAC was associated with treatment-refractory high Ki-67 scores and shorter recurrence-free survival. Finally, inhibition of mitogen-activated protein kinase kinase (MEK) synergized with docetaxel treatment in BLBC xenografts. Thus, DUSP4 downregulation activates the Ras-ERK pathway in BLBC, resulting in an attenuated response to anti-cancer chemotherapy.

NFL Players Using Violence Against Themselves – Is Gene TDP-43 In Adults And Gene MYCN or CD44 In Kids The Reason

Barron’s Medical Journal Reporting From The Home Of The Texans Reliant Park In Houston Texas

---

National Football League

Players Using violence Against Themselves – Is Gene TDP-43 In Adults And Gene MYCN or CD44 In Kids The Reason Why:

---

Folks are looking for answers to why too many National Football League players are using violence against themselves. Barrons Medical Journal ask Gennxeix Biotech CEO

for answers. To our surprise Rose Conrad Gennxeix CEO says that it has been known for years that some football players have a gene called TDP- 43. TAR DNA-binding protein of 43kDa (TDP-43). Genomics is again the key to equalize a patient’s risk. Conrads says new Genomics genetic risk factor for amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig's disease

There is no cure for ALS and the current treatment only slows disease progression. The identification of pathological interactions between ataxin 2 and TDP-43, another ALS-associated disease protein, together with the strong genetic association of ataxin 2 intermediate-length polyQ expansions and ALS, should aid in the development of biomarkers and empower the development of new therapies for this disease.

Parents can look for in their kids called Neuroblastoma. 8% of 30 Million Uninsured has Familial Cancer 1% of the 8% Kids has the ALK Gene on Chromosome2 that results in Neuroblastoma Cancer. Gennxeix Biotech Analytics Business Intelligence CIO Reports - 50% of the Moms with the Gene MYCN or CD44 Kids will have Neuroblastoma Cancer. The way Moms can recognized Neuroblastoma is a Abdominal Mass. The symptoms in high-risk patients are due to this tumor mass or bone pain from the cancer metastases. Extensive bone marrow metastasis may result in pancytopenia. Abdominal distention with respiratory compromise due to massive liver metastases may occur in infants. Because they originate in paraspinal ganglia, neuroblastomas may invade through neural foramina and compress the spinal cord extradurally, causing paralysis. The survival rate is twice as high if diagnosed in infants less that one years old. Genes that encode RNA-binding proteins (RBPs) such as PTB, hnRNP L, and SRSF1 are autoregulated to maintain a constant level of mRNA (Buratti and Baralle 2011). This autoregulatory process may be achieved in part by selective alternative splicing events that trigger nonsense-mediated decay (NMD)-mediated RNA degradation (Lejeune and Maquat 2005). The general term RUST (regulated unproductive splicing and translation) has been proposed to describe this category of gene regulation (Lareau et al. 2007a). Conrad also says that science labs use Genomics to generated multiple antibodies specific to phosphorylated TDP-43 by immunizing phosphopeptides of TDP-43, and analyzed

FTLD-U and ALS brains by immunohistochemistry, immunoelectron microscopy, and immunoblots. In addition, we performed investigations aimed at identifying the responsible kinases, and we assessed the effects of phosphorylation on TDP-43 oligomerization and fibrillization.

 Brought To You By gloStream

---

Barron's Medical Journal has called for a meeting between President Obama, Governor Rick Perry and President of MD Anderson Ronald DePinho, M.D. Medical Teams. The Objective is to put together a road map that will allow new born babies born Today to live 22 percent longer. President Obama Health Care Reform Act, Rick Perry commitment to Stem Cell Research, And Ronald DePinho & Jim Allison Chief of Immunology at MD Anderson vision and proven 24% success rate with immune research. Together it is clear, Genomic Science is here to stay.

The Status Of A Breast Cancer Cure

Barrons Medical Journal Interviews Hybrid Pharmaceutical, the Genomics Biotech

Engineering Company, CEO Rose Conrad Ph.D.

---

The Status Of A Breast Cancer Cure

---

From MD Anderson Galveston TX, Campus: Business Wire

---

Galveston ( AP ) Barrons Medical Journal reports that we are on our way to a breast

cancer cure. We now have the foundation to a Breast Cancer Cure. Leading the way is Genomics. Genomics has a few new partners. Starting the election of President Obama. President Obama Affordable Care Act. Governor Rick Perry dedication in the State Of Texas to provide a platform for any companies that is doing research on stem cells. Gennxeix Biotech model for detecting breast cancer using their 21 Gene cocktail of genes like P53, P63 and Her-1 to name a few, allows scientist and Doctors to do r

eal–time analysis of a patients breast cancer tumor Perform surgery to remove the tumor and replace to the cell with a stem cell from another part of your body. Breast cancer is the most common malignancy in United States women, accounting for >40,000 deaths each year. These breast tumors are comprised of phenotypically diverse populations of breast cancer cells. Using a model in which human breast cancer cells were grown in immunocompromised mice,

we found that only a minority of breast cancer cells had the ability to form new tumors. We were able to distinguish the tumorigenic (tumor initiating) from the nontumorigenic cancer cells based on cell surface marker expression Gennxeix Biotech Breast Cancer Researchers and Scientist are ahead of the curve with technologies based on Nanoparticles and Semi Conductors Namely Genomics and treatments.

 Brought To You By gloStream The field of genomics is caught in a data deluge. Targeted breast cancer DNA sequencing is becoming faster and cheaper at a pace far outstripping Moore’s law, which describes the rate at which computing gets faster and cheaper. The result is that the ability to determine Targeted breast cancer DNA sequences is starting to outrun the ability of researchers to store, transmit and especially to analyze the data. The cost of sequencing a human genome — all three billion bases of DNA in a set of human chromosomes — plunged to $10,000.00 which means genomics breast cancer DNA sequencing is around $3000.00. The lower cost, along with increasing speed, has led to a huge increase in how much breast Cancer sequencing data is being produced. Numerous investigations have shown that both tissue and cell distribution profiles can be controlled by their entrapment in submicronic colloidal systems (nanoparticles). The rationale behind this approach is to increase antitumor efficacy, while reducing systemic side-effects. This review provides an update of tumor targeting with conventional or long-circulating nanoparticles. The in vivo fate of these systems,

after intravascular or tumoral administration, is discussed, as well as the mechanism involved in tumor regression. Nanoparticles are also of benefit for the selective delivery of oligonucleotides to tumor cells. Moreover, certain types of nanoparticles showed some interesting capacity to reverse MDR resistance, which is a major problem in chemotherapy. The first experiments, aiming to decorate nanoparticles with molecular ligand for active targeting of cancerous cells Miniaturization will allow the tools for many different tests to be situated together on the same small device. Gennxeix Biotech Researchers Say that nanotechnology will allow them to run many diagnostic tests simultaneously. Nanoparticles nanoshells is use to antibodies that recognize cancer cells. GenNxeix scientist envisions letting these nanoshells seek out their cancerous targets, then applying near-infrared light. The heat generated by the light-absorbing nanoshells can successfully killed breast cancer tumor cells while leaving neighboring cells intact. A nanometer is a billionth of a meter. It's difficult to imagine anything so small, but think of something only 1/80,000 the width of a human hair. Ten hydrogen atoms side-by-side in a single nanometer. GenNxeix minuscule molecule that will be used to detect breast cancer is a quantum dot. Quantum dots are tiny crystals that glow when they are stimulated by ultraviolet light. The wavelength, or color, of the light depends on the size of the crystal. Latex beads filled with these crystals can be designed to bind to specific DNA sequences. Gennxeix Biotech understands that Hyperthermia gold nanoshell Targeted breast cancer genomics at 40 for high risk women will reduce breast cancer at 60 years of Age. Training Genomics Counselor and Storing DNA Analysis in the cloud will allow Gennxeix Biotech to say that Chemotherapy will help their breast cancer outcome or if Chemotheraphy and Hyperthermia will extend their life. Governor Rick Perry Texas' top ranking in the creation of biotech jobs, another sign that the Lone Star State is the place where high-tech visionaries of all types are planting their flags. However, very few of these fields are more promising, or important, than this one.

Adult stem cell research can change the world through regenerative medicine and its untapped potential to tackle some of the most challenging diseases known to man. GenNXeix Biotech Analytics Research has shown genomics, pluripotent stem (iPS) cells is the Future for Treating Breast Cancer along with Bacteria process called quorum sensing. Pluripotency (from the Latin plurimus, meaning very many, and potens, meaning having power) refers to a stem cell that has the potential to differentiate into any of the t hree germ layers: endoderm (interior stomach lining, gastrointestinal tract, the lungs), mesoderm (muscle, bone, blood, urogenital), or ectoderm (epidermal tissues and nervous system). Bacteria communicate with one another using chemical signal molecules. As in higher organisms, the information supplied by these molecules is critical for synchronizing the activities of large groups of cells. In bacteria, chemical communication involves producing, releasing, detecting, and responding to small hormone-like molecules termed auto inducers. This process, termed quorum sensing, allows bacteria to monitor the environment for other bacteria and to alter behavior on a population-wide scale in response to changes in the number and/or species present in a community. Most quorumsensing-controlled processes are unproductive when undertaken by an individual bacterium acting alone but become beneficial when carried out simultaneously by a large number of cells. Thus, quorum sensing confuses the distinction between prokaryotes and eukaryotes because it enables bacteria to act as multicellular organisms. This review focuses on the architectures of bacterial chemical communication networks; how chemical information is integrated, processed, and transduced to control gene expression; how intra- and interspecies cell-cell communication is accomplished; and the intriguing possibility of prokaryote-eukaryote cross-communication. They Final Key Bipartisn policy that President Obama and Governor Rick Perry agrees on is Electronic Medical Records. Gennxeix Medical System Announced Today Outsourcing of Electronic Medical Records from your location Doctors. Gennxeix The purpose of the GenNXeix Medical System Electronic Medical Record ("EHR") Service Level Agreement ("SLA") is to formalize our commitment to our valued health care professional users ("Clients"). Our SLA is intended to memorialize the specific level of support that we promise to provide to our Clients. This SLA may evolve over time, with additional knowledge of our Clients requirements, as well as the introduction of new application and services into the support portfolio, so please continue to check back for updates. ________________________________________ Definitions The following definitions shall apply to the GenNXeix Medical System EHR SLA. "Downtime" means, for the EHR, if there is more than a five percent (5%) of the user community issue rate. Downtime is measured based on server side issue rate. "Downtime Period" means, for the EHR, a period of ten consecutive minutes of Downtime. Intermittent Downtime for a period of less than ten minutes will not be counted towards any Downtime Periods. ________________________________________ "GenNXeix Medical System EHR Covered Services" means the GenNXeix Medical System Electronic Medical Record and Practice Management Service. This does not include the GenNXeix Medical System website, support site, or any other additional Gennxeix Medical Systems, Inc. branded site that does not pertain directly to the EHR system. "Monthly Uptime Percentage" means total number of minutes in a calendar month minus the number of minutes of Downtime suffered from all Downtime Periods in a calendar month, divided by the total number of minutes in a calendar month. "Scheduled Downtime" means those times where Gennxeix Medical Systems, Inc. notifies Client of periods of Downtime at least twenty four hours prior to the commencement of such Downtime. There will be no more than thirty-six hours of Scheduled Downtime per calendar year. Scheduled Downtime is not considered Downtime for purposes of this GenNXeix Medical System EHR SLA, and will not be counted towards any Downtime Periods.

Travel Far and long distance To Have A Great Christmas Or You Can Travel To The Best City In The United States For Holiday Fun and Festivities.

Barron’s Medical Journal Reporting on Black Friday From The Houston Galleria

---

Travel

Far and long distance To Have A Great Christmas Or You Can Travel To The Best City In The United States For Holiday Fun and Festivities.

---

Houston November 24,2012 ( AP ) Travel Far and long distance To Have A Great Christmas Or You Can Travel To The Best City In The United States For Holiday Fun and Festivities.

Who would of taught Houston would have some much to do from Family Entertainment to Single life activities. One of the best areas in the city of Houston For Entertainment is the Houston Galleria. In the Galleria every year is the Uptown Houston Holiday L

ighting to Dazzle City with Fireworks, Lights and Holiday Spirit 27TH Annual Event Kicks Off the Holiday Season

Brought To You By Antiques of River Oaks Houston,Tx   City Council District G spoke to the crowd of over 200,000 Houston folks and in a Interview with Barron Medical Journal Councilman said you can compare Houston with any city in the

United States or for that matter around the world and you will not find better hospitality and 82% percent of citizen that come to work in Houston stay in Houston. Oliver Pennington's life is one of education, hard work, dedication and achievement. B

orn and raised in Houston, he loves this city and everything it has to offer. Oliver achieved great success at a very young age. He graduated in 1960 from Rice University. From there he went on to law school at the University of Texas. He graduated in 1963. During that time he was an Associate Editor of the Texas Law Review. At 5 p.m., emcees KSBJ-FM’s Susan O’Donnell and BacktageOL.com’s Dave Morales introduced a Merry Holiday Stage Show with live performances by the Houston Concert Band, Houston Choral Showcase, Salvation Army Harbor Light Choir, Houston Children’s Chorus and more. Attendees can enjoy beverages and holiday treats available at concession stands and food trucks from local restaurants while enjoying the sounds of music and entertainment. As the excitement grows, Santa takes to the stage at 7 p.m. for a traditional countdown to illuminate Uptown Houston with half-a-million twinkling lights on 80 trees and buildings along Post Oak Boulevard. Immediately following, the spectacular fireworks extravaganza fills the Houston skies in a grand finale. The Hilton Houston Post Oak adds to the holiday cheer with its Annual Balcony Decorating Contest. Families participate in this competition year after year with creative holiday decorations, including lights and holiday garlands. A team of local celebrity judges will select the top three balconies and announce the winners before the night’s end. On The Same Day sponsored a 20 years Celebration of Thanksgiving tradition at the 2012 TXU Energy Turkey Trot benefiting Sheltering Arms Senior Services! The race will continue to take place at Dillard’s near the Galleria on Thanksgiving Day. TXU Energy Turkey Trot Milestones: 2005: Runner participation was 4,000. 2010: The TXU Energy Turkey Trot moves from its long-time start location in Uptown Park to its current location at Dillard’s by the Galleria. 2011: The TXU Energy Turkey Trot reaches a record 12,000+ participants. The most senior runner is 86 years old. The Trot becomes the third largest footrace of its kind in the Houston area. Our 2012 Grand Marshal: Olympic Bronze Medalist Marlen Esparza! Sheltering Arms Senior Services and TXU Energy are proud to announce boxing champion Marlen Esparza as the official Grand Marshal of the 20th Annual TXU Energy Turkey Trot benefiting Sheltering Arms Senior Services, taking place Thanksgiving morning, November 22, at Dillard’s by the Galleria. As Grand Marshal, Ms. Esparza will officially fire the gun to announce the start of each race.

 Brought To You By gloStream In the middle of all The Texans Football Team won their second over time game. This is why Breast cancer and other diseases will have a cure found in Houston for no other reason other than the quality of Life some many enjoy in Houston

President Obama, Governor Rick Perry and President of MD Anderson Ronald DePinho, M.D. Medical Teams To Meet Next Year

Barron's Medical Journal Reporting From Baylor College Of Medicine, Houston Medical Center, Houston, Texas

---

President Obama, Governor Rick Perry and President of MD Anderson Ronald DePinho, M.D. Medical Teams To Meet Next Year.

---

Houston ( AP )Barron's Medical Journal has called for a meeting between President Obama, Governor Rick Perry and President of MD Anderson Ronald DePinho, M.D. Medical Teams. The Objective is to put together a road map that will allow new born babies born Today to live 22 percent longer. President Obama Health Care Reform Act, Rick Perry commitment to Stem Cell Research,

And Ronald DePinho & Jim Allison Chief of Immunology at MD Anderson vision and proven 24% success

rate with immune research. Together it is clear, Genomic Science and the protein to allow your immune system to stop the advancement of Breast Cancer Tumors is the cure for Breast Cancer.

Brought To You By Antiques of River Oaks Houston,Tx Jim Allison’s discoveries led to the first drug ever to improve the survival rate of patients with metastatic melanoma – by itself a remarkable achievement. His insights into the basic biology of immune system T cells will be broadly applicable to a

variety of cancers and his gifted scientific leadership is essential to the definitive progress that must be made against these diseases,” said MD Anderson President Ronald DePinho, M.D. “We’re delighted that he will lead our collaborative immunotherapy initiative to continue unleashing the power of the immune system against cancer,” DePinho said. “Dr. Allison embodies an important principle for us. It’s not just about doing elegant science, although that’s certainly the case here. It doesn’t count unless it has a meaningful impact on the well-being of our patients. That’s the bottom line.” Accelerating transition of drug combinations to clinic “The main reason for coming to MD Anderson is the opportunity offered by a clinical community that’s open to using immunological approaches to treat cancer combined with other therapies,” Allison said. “We plan to build a large platform where basic scientists interested in mouse models of cancer work side-by-side with physician-scientists who treat patients to analyze tissues from those patients and truly understand the mechanisms involved,” Allison said. “We can accelerate the transition of new combinations of drugs into the clinic beyond phase I clinical trials and broaden our focus beyond melanoma and prostate cancer to other types of cancer. “We all know that no single drug will cure cancer. I think this is where we’ll start getting cures, or at least long-term survival of patients. There’s lots of enthusiasm for this approach at MD Anderson and I’m really excited about it,” he said. Allison will play an instrumental role in MD Anderson’s recently announced Moon Shots Program to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths. He is a member of the National Academy of Sciences and the Institute of Medicine, as well as a fellow of the American Academy of Microbiology and the American Association for the Advancement of Science. He also is an investigator of the Howard Hughes Medical Institute. Allison was chair of the immunology program and director of the Ludwig Center for

Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center in New York.He started at MD Anderson on Nov. 1. Immune system personalizes therapy

Rather than attacking cancer cells directly, the drug developed from Allison’s research makes those cells “visible” to the immune system by blocking a molecule he discovered that inhibits immune response. About 25 percent of patients with late stage metastatic melanoma who took ipilimumab in clinical trials have lived for five years or longer. The drug, known commercially as Yervoy, was approved by the U.S. Food and Drug Administration in May 2011. Governor Rick Perry Texas' top ranking in the creation of biotech jobs, another sign that the Lone Star State is the place where high-tech visionaries of all types are planting their flags. However, very few of these fields are more promising, or important, than this one. Adult stem cell research can change the world through regenerative medicine and its untapped potential to tackle some of the most challenging diseases known to man. GenNXeix Biotech Analytics Research has shown genomics, pluripotent stem (iPS) cells is the Future for Treating Breast Cancer along with Bacteria process called quorum sensing. Pluripotency (from the Latin plurimus, meaning very many, and potens, meaning having power) refers to a stem cell that has the potential to differentiate into any of the three germ layers: endoderm (interior stomach lining, gastrointestinal tract, the lungs), mesoderm (muscle, bone, blood, urogenital), or ectoderm (epidermal tissues and nervous system). Bacteria communicate with one another using chemical signal molecules. As in higher organisms, the information supplied by these molecules is critical for synchronizing the activities of large groups of cells. In bacteria, chemical communication involves producing, releasing, detecting, and responding to small hormone-like molecules termed auto inducers. This process, termed quorum sensing, allows bacteria to monitor the environment for other bacteria and to alter behavior on a population-wide scale in response to changes in the number and/or species present in a community. Most quorumsensing-controlled processes are unproductive when undertaken by an individual bacterium acting alone but become beneficial when carried out simultaneously by a large number of cells. Thus, quorum sensing confuses the distinction between prokaryotes and eukaryotes because it enables bacteria to act as multicellular organisms. This review focuses on the architectures of bacterial chemical communication networks; how chemical information is integrated, processed, and transduced to control gene expression; how intra- and interspecies cell-cell communication is accomplished; and the intriguing possibility of prokaryote-eukaryote cross-communication. Together along with several new Biotech companies moving to Texas. A great example of companies is GenNXeix Medical Systems.

Brought To You By gloStream

---

"GenNXeix Medical System EHR Covered Services" means the GenNXeix Medical System Electronic Medical Record and Practice Management Service. This does not include the GenNXeix Medical System website, support site, or any other additional Gennxeix Medical Systems, Inc. branded site that does not pertain directly to the EHR system. "Monthly Uptime Percentage" means total number of minutes in a calendar month minus the number of minutes of Downtime suffered from all Downtime Periods in a calendar month, divided by the total number of minutes in a calendar month. "Scheduled Downtime" means those times where Gennxeix Medical Systems, Inc. notifies Client of periods of Downtime at least twenty four hours prior to the commencement ofsuch Downtime. There will be no more than thirty six hours of Scheduled Downtime per calendar year. Scheduled Downtime is not considered Downtime for purposes of this GenNXeix Medical System EHR SLA, and will not be counted towards any Downtime Periods. Barron's Medical Journal is predicting that a cure for breast caner will becoming during the second President Obama Administration.

Barron's Medical Journal Under The Hood In Houston - A Week Of "Ferrari's, Films And Fashion "

Barron's Medical Journal Under The Hood In Houston - A Week Of "Ferrari's, Film And Fashion ".

---

Robert Graham Ph.D. Reporting From Houston Texas

---

Houston ( AP ) Barron's Medical Journal covering the Houston Ferrari Festival, Cinema Arts Festival, And & Fashion Week Houston, We discovered, Houston one of the Haute Couture life styles cities in the United States.

With NASA, Oil and Gas and The Houston Medical Center there is so much disposal income Flowing around H-Town, Stars from Hollywood Robert Redford, Designer Laurel Berman, and Houston-based Risi Competizione Ferrari's Racing Team Compels Barron's Medical Journal to Rate Houston as The Second Best City in The United State behind New York City For Single And Professional.

Brought To You By Remotizer Use Your Key Or Remote To Open Your Door Stocking Stuffier